Dernières publications scientifiques

  • Real-world Effectiveness and Safety of Risankizumab in Patients with Moderate to Severe Multirefractory Crohn's Disease: A Belgian Multicentric Cohort Study.

  • Auteurs Alsoud D, Sabino J, Franchimont D, Cremer A, Busschaert J, D'Heygere F, Bossuyt P, Vijverman A, Vermeire S, Ferrante M
  • Auteurs (entité) Franchimont Denis
  • Revue Inflamm Bowel Dis
  • Date de publication 2024-01
Real-world Effectiveness and Safety of Risankizumab in Patients with Moderate to Severe Multirefractory Crohn's Disease: A Belgian Multicentric Cohort Study.
  • Real-world Effectiveness and Safety of Risankizumab in Patients with Moderate to Severe Multirefractory Crohn's Disease: A Belgian Multicentric Cohort Study.

  • Auteurs Alsoud D, Sabino J, Franchimont D, Cremer A, Busschaert J, D'Heygere F, Bossuyt P, Vijverman A, Vermeire S, Ferrante M
  • Auteurs (entité) Cremer Anneline
  • Revue Inflamm Bowel Dis
  • Date de publication 2024-01
Real-world Effectiveness and Safety of Risankizumab in Patients with Moderate to Severe Multirefractory Crohn's Disease: A Belgian Multicentric Cohort Study.
  • The Utilisation of Digital Applications for Measuring Patient Outcomes Following Bariatric Surgery: a Systematic Review and Meta-analysis of Comparative Studies.

  • Auteurs Farinella E, Koliakos N, Papakonstantinou D, Breuer N, Pau L, Poras M, Maréchal MT, Briganti G
  • Auteurs (entité) Farinella Eleonora
  • Revue Obes Surg
  • Date de publication 2024-01
The Utilisation of Digital Applications for Measuring Patient Outcomes Following Bariatric Surgery: a Systematic Review and Meta-analysis of Comparative Studies.
Bordet hospital

Institut Jules Bordet

Consultez toutes les publications scientifiques de Jules Bordet

Erasme hospital

Hôpital Erasme

Consultez toutes les publications scientifiques d'Erasmus

Huderf hospital

Hôpital pédiatrique Reine Fabiola

Voir toutes les publications scientifiques de l'Hôpital pédiatrique Reine Fabiola